Denosumab and fracture risk in women with breast cancer

Lancet. 2015 Aug 1;386(9992):409-10. doi: 10.1016/S0140-6736(15)61032-7. Epub 2015 May 31.

Authors

Robert Coleman¹, Peyman Hadji²

Affiliations

¹ Sheffield Cancer Research Centre, Weston Park Hospital, Sheffield S10 2SJ, UK. Electronic address: [email protected].
² Krankenhaus Nordwest, Frankfurt, Germany.

PMID: 26040500
DOI: 10.1016/S0140-6736(15)61032-7

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Breast Neoplasms / complications*
Female
Fractures, Bone*
Humans

Substances

Antibodies, Monoclonal, Humanized